Asset Management Corp Biocryst Pharmaceuticals Inc Transaction History
Asset Management Corp
- $146 Million
- Q1 2023
A detailed history of Asset Management Corp transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Asset Management Corp holds 17,000 shares of BCRX stock, worth $120,020. This represents 0.15% of its overall portfolio holdings.
Number of Shares
17,000Holding current value
$120,020% of portfolio
0.15%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BCRX
# of Institutions
279Shares Held
172MCall Options Held
625KPut Options Held
739K-
Vanguard Group Inc Valley Forge, PA20.3MShares$143 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$141 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$83.8 Million1.36% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$64.1 Million5.66% of portfolio
-
State Street Corp Boston, MA8.85MShares$62.5 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.31B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...